These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8835749)

  • 1. Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope.
    Bruck R; Hershkoviz R; Lider O; Aeed H; Zaidel L; Matas Z; Barg J; Halpern Z
    J Hepatol; 1996 Jun; 24(6):731-8. PubMed ID: 8835749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury.
    Bruck R; Hershkoviz R; Lider O; Shirin H; Aeed H; Halpern Z
    Yale J Biol Med; 1997; 70(4):391-402. PubMed ID: 9626759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpeptidic analogues of the Arg-Gly-Asp (RGD) sequence specifically inhibit the adhesion of human tenon's capsule fibroblasts to fibronectin.
    Hershkoviz R; Melamed S; Greenspoon N; Lider O
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2585-91. PubMed ID: 8163346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope.
    Hershkoviz R; Lider O; Bruck R; Aeed H; Greenspoon N; Halpern Z
    J Hepatol; 1995 Feb; 22(2):158-64. PubMed ID: 7540635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
    Bruck R; Hershkoviz R; Lider O; Shirin H; Aeed H; Halpern Z
    Isr Med Assoc J; 2000 Jul; 2 Suppl():74-80. PubMed ID: 10909422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic Arg-Gly-Asp mimetics.
    Hardan I; Weiss L; Hershkoviz R; Greenspoon N; Alon R; Cahalon L; Reich S; Slavin S; Lider O
    Int J Cancer; 1993 Dec; 55(6):1023-8. PubMed ID: 7504656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of integrin recognition and the inhibition of integrin-mediated cell functions by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence.
    Greenspoon N; Hershkoviz R; Alon R; Varon D; Shenkman B; Marx G; Federman S; Kapustina G; Lider O
    Biochemistry; 1993 Feb; 32(4):1001-8. PubMed ID: 8093840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of experimentally induced cirrhosis in rats by hypothyroidism.
    Oren R; Dotan I; Papa M; Marravi Y; Aeed H; Barg J; Zeidel L; Bruck R; Halpern Z
    Hepatology; 1996 Aug; 24(2):419-23. PubMed ID: 8690414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
    Reif S; Aeed H; Shilo Y; Reich R; Kloog Y; Kweon YO; Bruck R
    J Hepatol; 2004 Aug; 41(2):235-41. PubMed ID: 15288472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly-Asp.
    Hershkoviz R; Greenspoon N; Mekori YA; Hadari R; Alon R; Kapustina G; Lider O
    Clin Exp Immunol; 1994 Feb; 95(2):270-6. PubMed ID: 7905794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
    Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
    Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
    Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
    Reif S; Weis B; Aeed H; Gana-Weis M; Zaidel L; Avni Y; Romanelli RG; Pinzani M; Kloog Y; Bruck R
    J Hepatol; 1999 Dec; 31(6):1053-61. PubMed ID: 10604579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of liver cirrhosis in rats by curcumin.
    Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
    Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    Dig Dis Sci; 1993 Dec; 38(12):2195-202. PubMed ID: 8261820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice.
    Bruck R; Shirin H; Hershkoviz R; Lider O; Kenet G; Aeed H; Matas Z; Zaidel L; Halpern Z
    Gut; 1997 Jan; 40(1):133-8. PubMed ID: 9155591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium and liver cirrhosis.
    Al-Bader A; Abul H; Hussain T; Al-Moosawi M; Mathew TC; Dashti H
    Mol Cell Biochem; 1998 Aug; 185(1-2):1-6. PubMed ID: 9746205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-carotene attenuates experimentally induced liver cirrhosis in rats.
    Wardi J; Reifen R; Aeed H; Zadel L; Avni Y; Bruck R
    Isr Med Assoc J; 2001 Feb; 3(2):151-4. PubMed ID: 11344828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.